Markets
Leaderboard
Will any mRNA-based treatment (NOT a vaccine) against COVID-19 be approved by the end of 2023? No: real money 74%, play money 67% Yes: real money 26%, play money 33% Volume: real money 271.49044246, play money 11404.54 Bettors: real money 6, play money 36 Categories: Science, Transmissible Diseases, Covid-19 (Coronavirus), Treatments Related markets Nipah virus declared a public health emergency by the WHO in 2026? (ID: 233776) Volume: real 100.18015496, play 14933.4347 Bettors: real 4, play 3 Leading (real money): Nipah virus declared a public health emergency by the WHO in 2026? 11% Leading (play money): Nipah virus declared a public health emergency by the WHO in 2026? 7% Antarctic sea ice minimum to decrease in 2027? (ID: 235045) Volume: real 500.10026694, play 50000 Bettors: real 4, play 0 Leading (real money): Antarctic sea ice minimum to decrease in 2027? 81% Leading (play money): Antarctic sea ice minimum to decrease in 2027? 81%

Will any mRNA-based treatment (NOT a vaccine) against COVID-19 be approved by the end of 2023?

Market Rules

The search for COVID-19 treatments has been ongoing since the beginning of the pandemic, but experiments returned promising results. However, a new strategy is surging in the form of mRNA.

Biotech company Kernal Biologics claims to be working on an mRNA 2.0. Their strategy is to transform the patient's cells into drug factories that could produce the active substance on-site, where the virus is causing more damage, like the lungs.

If any mRNA-based treatment against COVID-19 gets approval for use in the general public by the end of 2023, this market will be resolved as "Yes".

Futuur will consider treatments developed either by Kernal Biologics or any other company. To determine that the drug has been approved, Futuur will take into account decisions by the following health agencies: ANVISA (Brazil), FDA (USA), EMA (European Union), MHRA (United Kingdom), NMPA (China), or PMDA (Japan).

Comments

  • palio22: aqui
  • palio22: aqui

Related Markets